請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73927
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝淑貞(Shu-Chen Hsieh) | |
dc.contributor.author | Meng-Chuan Lung | en |
dc.contributor.author | 龍孟專 | zh_TW |
dc.date.accessioned | 2021-06-17T08:13:59Z | - |
dc.date.available | 2021-02-22 | |
dc.date.copyright | 2021-02-22 | |
dc.date.issued | 2021 | |
dc.date.submitted | 2021-01-27 | |
dc.identifier.citation | 1. 衛生福利部國民健康署, 中華民國 107年癌症登記報告. 2020. 2. American Cancer Society, Colorectal-cancer-facts-and-figures-2020-2022. American Cancer Society journal 2020. 3. American Cancer Society, SEER cancer statistics review 1975-2016. 2020. 4. Weiser, M. R., AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol 2018, 25 (6), 1454-1455. 5. Fearon, E. R.; Vogelstein, B., A genetic model for colorectal tumorigenesis. Cell 1990, 61 (5), 759-767. 6. Stanczak, A.; Stec, R.; Bodnar, L.; Olszewski, W.; Cichowicz, M.; Kozlowski, W.; Szczylik, C.; Pietrucha, T.; Wieczorek, M.; Lamparska-Przybysz, M., Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma. Pathol Oncol Res 2011, 17 (4), 955-63. 7. Levine, A. J., p53, the cellular gatekeeper for growth and division. Cell 1997, 88 (3), 323-31. 8. Leslie, A.; Carey, F. A.; Pratt, N. R.; Steele, R. J., The colorectal adenoma-carcinoma sequence. Br J Surg 2002, 89 (7), 845-60. 9. Van der Geest, L. G.; Lam-Boer, J.; Koopman, M.; Verhoef, C.; Elferink, M. A.; de Wilt, J. H., Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis 2015, 32 (5), 457-65. 10. Hugen, N.; van de Velde, C. J. H.; de Wilt, J. H. W.; Nagtegaal, I. D., Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol 2014, 25 (3), 651-657. 11. Paschos, K. A.; Majeed, A. W.; Bird, N. C., Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance. World J Gastroenterol 2014, 20 (14), 3719-37. 12. Valastyan, S.; Weinberg, R. A., Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147 (2), 275-92. 13. Hanahan, D.; Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100 (1), 57-70. 14. Haneda, M.; Kojima, E.; Nishikimi, A.; Hasegawa, T.; Nakashima, I.; Isobe, K., Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett 2004, 567 (2-3), 171-4. 15. Vousden, K. H.; Lu, X., Live or let die: the cell's response to p53. Nat Rev Cancer 2002, 2 (8), 594-604. 16. Paget, S., The distribution of secondary growths in cancer of the breast. The Lancet 1889, 133 (3421), 571-573. 17. Hanahan, D.; Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011, 144 (5), 646-74. 18. Greenburg, G.; Hay, E. D., Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 1982, 95 (1), 333-339. 19. Miettinen, P. J.; Ebner, R.; Lopez, A. R.; Derynck, R., TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994, 127 (6 Pt 2), 2021-36. 20. Li, Y.; Bhargava, M. M.; Joseph, A.; Jin, L.; Rosen, E. M.; Goldberg, I. D., Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Dev Biol Anim 1994, 30a (2), 105-10. 21. Timmerman, L. A.; Grego-Bessa, J.; Raya, A.; Bertrán, E.; Pérez-Pomares, J. M.; Díez, J.; Aranda, S.; Palomo, S.; McCormick, F.; Izpisúa-Belmonte, J. C.; de la Pompa, J. L., Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004, 18 (1), 99-115. 22. Shapiro, L.; Weis, W. I., Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 2009, 1 (3), a003053. 23. Green, K. J.; Getsios, S.; Troyanovsky, S.; Godsel, L. M., Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2010, 2 (2), a000125. 24. Behrens, J.; Vakaet, L.; Friis, R.; Winterhager, E.; Van Roy, F.; Mareel, M. M.; Birchmeier, W., Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993, 120 (3), 757-66. 25. Brabletz, T.; Jung, A.; Reu, S.; Porzner, M.; Hlubek, F.; Kunz-Schughart, L. A.; Knuechel, R.; Kirchner, T., Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 2001, 98 (18), 10356-61. 26. Wels, C.; Joshi, S.; Koefinger, P.; Bergler, H.; Schaider, H., Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma. J Invest Dermatol 2011, 131 (9), 1877-85. 27. VanderVorst; Kacey Dreyer; Courtney A.Konopelski; Sara E.Lee; Hyun Ho; Hsin-Yi Henry Carraway; L., K., Wnt/PCP signaling contribution to carcinoma collective cell migration and metastasis. Cancer Research 2019, 79 (8), 1719-1729. 28. Hegerfeldt, Y.; Tusch, M.; Bröcker, E. B.; Friedl, P., Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res 2002, 62 (7), 2125-30. 29. Bui, J.; Conway, D. E.; Heise, R. L.; Weinberg, S. H., Mechanochemical coupling and junctional forces during collective cell migration. Biophysical Journal 2019, 117 (1), 170-183. 30. Trepat, X.; Fredberg, J. J., Plithotaxis and emergent dynamics in collective cellular migration. Trends Cell Biol 2011, 21 (11), 638-46. 31. Aman, A.; Piotrowski, T., Wnt/beta-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression. Dev Cell 2008, 15 (5), 749-61. 32. Cheung, K. J.; Ewald, A. J., A collective route to metastasis: Seeding by tumor cell clusters. Science 2016, 352 (6282), 167-9. 33. Yu, M.; Bardia, A.; Wittner, B. S.; Stott, S. L.; Smas, M. E.; Ting, D. T.; Isakoff, S. J.; Ciciliano, J. C.; Wells, M. N.; Shah, A. M.; Concannon, K. F.; Donaldson, M. C.; Sequist, L. V.; Brachtel, E.; Sgroi, D.; Baselga, J.; Ramaswamy, S.; Toner, M.; Haber, D. A.; Maheswaran, S., Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339 (6119), 580-584. 34. Aceto, N.; Bardia, A.; Miyamoto, D. T.; Donaldson, M. C.; Wittner, B. S.; Spencer, J. A.; Yu, M.; Pely, A.; Engstrom, A.; Zhu, H.; Brannigan, B. W.; Kapur, R.; Stott, S. L.; Shioda, T.; Ramaswamy, S.; Ting, D. T.; Lin, C. P.; Toner, M.; Haber, D. A.; Maheswaran, S., Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014, 158 (5), 1110-1122. 35. Chung, Y. C.; Wei, W. C.; Hung, C. N.; Kuo, J. F.; Hsu, C. P.; Chang, K. J.; Chao, W. T., Rab11 collaborates E-cadherin to promote collective cell migration and indicates a poor prognosis in colorectal carcinoma. Eur J Clin Invest 2016, 46 (12), 1002-1011. 36. Theocharis, A. D.; Skandalis, S. S.; Gialeli, C.; Karamanos, N. K., Extracellular matrix structure. Advanced Drug Delivery Reviews 2016, 97, 4-27. 37. Abedin, M.; King, N., Diverse evolutionary paths to cell adhesion. Trends in Cell Biology 2010, 20 (12), 734-742. 38. Holle, A. W.; Young, J. L.; Van Vliet, K. J.; Kamm, R. D.; Discher, D.; Janmey, P.; Spatz, J. P.; Saif, T., Cell–extracellular matrix mechanobiology: forceful tools and emerging needs for basic and translational research. Nano Letters 2018, 18 (1), 1-8. 39. Wary, K. K., Recognizing scientific excellence in the biology of cell adhesion. Cell Communication and Signaling 2005, 3 (1), 7. 40. Hynes, R. O., Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110 (6), 673-87. 41. Webb, D. J.; Parsons, J. T.; Horwitz, A. F., Adhesion assembly, disassembly and turnover in migrating cells – over and over and over again. Nature Cell Biology 2002, 4 (4), E97-E100. 42. Chong, Y. P.; Mulhern, T. D.; Cheng, H. C., C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases. Growth Factors 2005, 23 (3), 233-44. 43. Dehm, S. M.; Bonham, K., SRC gene expression in human cancer: the role of transcriptional activation. Biochem Cell Biol 2004, 82 (2), 263-74. 44. Talamonti, M. S.; Roh, M. S.; Curley, S. A.; Gallick, G. E., Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. The Journal of Clinical Investigation 1993, 91 (1), 53-60. 45. Fang, X. Q.; Liu, X. F.; Yao, L.; Chen, C. Q.; Gu, Z. D.; Ni, P. H.; Zheng, X. M.; Fan, Q. S., Somatic mutational analysis of FAK in breast cancer: a novel gain-of-function mutation due to deletion of exon 33. Biochem Biophys Res Commun 2014, 443 (2), 363-9. 46. Schlaepfer, D. D.; Mitra, S. K.; Ilic, D., Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2004, 1692 (2), 77-102. 47. Westhoff, M. A.; Serrels, B.; Fincham, V. J.; Frame, M. C.; Carragher, N. O., Src-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Molecular and Cellular Biology 2004, 24 (18), 8113-8133. 48. Irby, R. B.; Yeatman, T. J., Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Research 2002, 62 (9), 2669-74. 49. Serrels, A.; Canel, M.; Brunton, V. G.; Frame, M. C., Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging. Cell Adh Migr 2011, 5 (4), 360-365. 50. Veracini, L.; Grall, D.; Schaub, S.; Beghelli-de la Forest Divonne, S.; Etienne-Grimaldi, M.-C.; Milano, G.; Bozec, A.; Babin, E.; Sudaka, A.; Thariat, J.; Van Obberghen-Schilling, E., Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas. Oncotarget 2015, 6 (10), 7570-7583. 51. Frisch, S. M.; Francis, H., Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124 (4), 619-26. 52. Frisch, S. M.; Screaton, R. A., Anoikis mechanisms. Current Opinion in Cell Biology 2001, 13 (5), 555-562. 53. Windham, T. C.; Parikh, N. U.; Siwak, D. R.; Summy, J. M.; McConkey, D. J.; Kraker, A. J.; Gallick, G. E., Src activation regulates anoikis in human colon tumor cell lines. Oncogene 2002, 21 (51), 7797-7807. 54. Schaller, M. D., Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2001, 1540 (1), 1-21. 55. Schlaepfer, D. D.; Hunter, T., Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem 1997, 272 (20), 13189-95. 56. Moro, L.; Dolce, L.; Cabodi, S.; Bergatto, E.; Boeri Erba, E.; Smeriglio, M.; Turco, E.; Retta, S. F.; Giuffrida, M. G.; Venturino, M.; Godovac-Zimmermann, J.; Conti, A.; Schaefer, E.; Beguinot, L.; Tacchetti, C.; Gaggini, P.; Silengo, L.; Tarone, G.; Defilippi, P., Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem 2002, 277 (11), 9405-14. 57. Bouchard, V.; Demers, M. J.; Thibodeau, S.; Laquerre, V.; Fujita, N.; Tsuruo, T.; Beaulieu, J. F.; Gauthier, R.; Vézina, A.; Villeneuve, L.; Vachon, P. H., Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol 2007, 212 (3), 717-28. 58. Wei, H., Peng, W., Mao, Y. M., Chemical constituents of fruit from Canarium album. China Journal of Chinese Material Medicine 1999, 24, 421-423. 59. Ding, B., Pharmacology of qingguo pills on relieving cough. China Tradit. Pat. Med. 1999, 21, 27-28. 60. He, Z.; Xia, W., Nutritional composition of the kernels from Canarium album L. Food Chemistry - FOOD CHEM 2007, 102, 808-811. 61. He, Z.; Xia, W., Analysis of phenolic compounds in chinese olive (Canarium album L.) fruit by RPHPLC-DAD-ESI-MS. Food Chemistry 2007, 105, 1307-1311. 62. Yeh, Y. T.; Chiang, A. N.; Hsieh, S. C., Chinese olive (Canarium album L.) fruit extract attenuates metabolic dysfunction in diabetic rats. Nutrients 2017, 9 (10). 63. Kuo, C. T.; Liu, T. H.; Hsu, T. H.; Lin, F. Y.; Chen, H. Y., Antioxidant and antiglycation properties of different solvent extracts from Chinese olive (Canarium album L.) fruit. Asian Pacific Journal of Tropical Medicine 2015, 8 (12), 1013-1021. 64. Wang, C. H.; Lin, J. H.; Lu, T. J.; Chiang, A. N.; Chiou, S. T.; Chen, Y. A.; Pan, M. H.; Hsieh, S. C., Establishment of reporter platforms capable of detecting NF-κB mediated immuno-modulatory activity. Journal of Agricultural and Food Chemistry 2013, 61 (51), 12582-12587. 65. Kuo, Y. H.; Yeh, Y. T.; Pan, S. Y.; Hsieh, S. C., Identification and structural elucidation of anti-inflammatory compounds from Chinese Olive (Canarium Album L.) fruit extracts. Foods 2019, 8 (10). 66. Yeh, Y. T.; Cho, Y. Y.; Hsieh, S. C.; Chiang, A. N., Chinese olive extract ameliorates hepatic lipid accumulation in vitro and in vivo by regulating lipid metabolism. Scientific Reports 2018, 8 (1). 67. Yeh, Y. T.; Lu, T. J.; Lian, G. T.; Lung, M. C.; Lee, Y. L.; Chiang, A. N.; Hsieh, S. C., Chinese olive (Canarium album L.) fruit regulates glucose utilization by activating AMP-activated protein kinase. Faseb j 2020, 34 (6), 7866-7884. 68. Hsieh, S. C.; Hsieh, W. J.; Chiang, A. N.; Su, N. W.; Yeh, Y. T.; Liao, Y. C., The methanol-ethyl acetate partitioned fraction from Chinese olive fruits inhibits cancer cell proliferation and tumor growth by promoting apoptosis through the suppression of the NF-κB signaling pathway. Food Funct 2016, 7 (12), 4797-4803. 69. 練冠霆, 運用熱穩定分析探討中國橄欖萃取物在大腸直腸癌細胞株的蛋白質標的與促進細胞凋亡機制. 臺灣大學食品科技研究所 2020. 70. 葉昱德, 中國橄欖之抗增生活性因子的純化及鑑定暨其生理活性之研究. 臺灣大學食品科技研究所2013. 71. Yang, C.; Xie, X. Y.; Tang, H.; Dong, X. Y.; Zhang, X. D.; Huang, F. H., Transcriptome analysis reveals GA induced apoptosis in HCT116 human colon cancer cells through calcium and p53 signal pathways. Rsc Advances 2018, 8 (22), 12449-12458. 72. Fang, Y.; Zhou, H.; Xia, J. F.; Lin, J. J.; Li, R. Z.; Yang, D. Q.; Xu, M. Y.; Li, X. Y., Ellagic acid regulates Wnt/beta-catenin signaling pathway and CDK8 in HCT 116 and HT 29 colon cancer cells. Bangladesh Journal of Pharmacology 2015, 10 (1), 47-56. 73. Umesalma, S.; Sudhandiran, G., Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappa B, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clinical Pharmacology Toxicology 2010, 107 (2), 650-655. 74. Hudson, E. A.; Dinh, P. A.; Kokubun, T.; Simmonds, M. S. J.; Gescher, A., Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiology Biomarkers amp;amp; Prevention 2000, 9 (11), 1163-70. 75. Gong, J. L.; Zhou, S. X.; Yang, S. H., Vanillic acid suppresses HIF-1 expression via inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK pathways in human colon cancer HCT116 cells. International Journal of Molecular Sciences 2019, 20 (3). 76. Zitta, K.; Meybohm, P.; Bein, B.; Huang, Y.; Heinrich, C.; Scholz, J.; Steinfath, M.; Albrecht, M., Salicylic acid induces apoptosis in colon carcinoma cells grown in-vitro: Influence of oxygen and salicylic acid concentration. Experimental Cell Research 2012, 318 (7), 828-834. 77. Park, S. S.; Park, S. K.; Lim, J. H.; Choi, Y. H.; Kim, W. J.; Moon, S. K., Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells. Oncology Reports 2011, 25 (1), 223-230. 78. Li, T.; Zhang, L.; Huo, X. K., Inhibitory effects of aesculetin on the proliferation of colon cancer cells by the Wnt/beta-catenin signaling pathway. Oncology Letters 2018, 15 (5), 7118-7122. 79. Kim, H. J.; Kim, S. K.; Kim, B. S.; Lee, S. H.; Park, Y. S.; Park, B. K.; Kim, S. J.; Kim, J.; Choi, C.; Kim, J. S.; Cho, S. D.; Jung, J. W.; Roh, K. H.; Kang, K. S.; Jung, J. Y., Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. Journal of Agricultural and Food Chemistry 2010, 58 (15), 8643-8650. 80. Priego, S.; Feddi, F.; Ferrer, P.; Mena, S.; Benlloch, M.; Ortega, A.; Carretero, J.; Obrador, E.; Asensi, M.; Estrela, J. M., Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Mol Cancer Ther 2008, 7 (10), 3330-42. 81. Shan, B. E.; Wang, M. X.; Li, R. Q., Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009, 27 (6), 604-12. 82. Li, W.; Du, B. N.; Wang, T. Y.; Wang, S. L.; Zhang, J. H., Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis. Chemico-Biological Interactions 2009, 177 (2), 121-127. 83. Lee, H. S.; Cho, H. J.; Yu, R.; Lee, K. W.; Chun, H. S.; Park, J. H. Y., Mechanisms underlying apoptosis-inducing effects of kaempferol in HT-29 human colon cancer cells. International Journal of Molecular Sciences 2014, 15 (2), 2722-2737. 84. Pandurangan, A. K.; Esa, N. M., Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review. Asian Pacific Journal of Cancer Prevention 2014, 15 (14), 5501-5508. 85. Kuai, X. Y.; Pang, Z.; Shao, X. Y.; Zhang, L. P.; Xu, X. F.; Zhou, C. L., Effects of luteolin on the expressions of TGF-beta 1R II, NF-kappa B, and VEGF genes in tumor tissues of mice with H29 colon cancer. Analytical and Quantitative Cytopathology and Histopathology 2018, 40 (2), 69-75. 86. Nasiri, F.; Kismali, G.; Sel, T., Rutin inhibits cells growth and suppreses inflammation by inhibiting NFkB and COX-2 activities in colon cancer cells. Anti-Cancer Drugs 2015, 26, E10-E10. 87. Guon, T. E.; Chung, H. S., Hyperoside and rutin of Nelumbo nucifera induce mitochondrial apoptosis through a caspase-dependent mechanism in HT-29 human colon cancer cells. Oncology Letters 2016, 11 (4), 2463-2470. 88. 葉昱德, 中國橄欖萃取物對脂質與醣類代謝相關機制的探討. 臺灣大學食品科技研究所2018. 89. 彭芝皜, 中國橄欖萃取物於不同葡萄糖濃度下造成人類大腸癌細胞生長情形差異及其相關機制之探討. 臺灣大學食品科技研究所 2019. 90. Kobayashi, A.; Hirakawa, H.; Hirata, T.; Nishino, K.; Yamaguchi, A., Growth phase-dependent expression of drug exporters in Escherichia coli and its contribution to drug tolerance. J Bacteriol 2006, 188 (16), 5693-5703. 91. Zhao, L.; Au, J. L. S.; Wientjes, M. G., Comparison of methods for evaluating drug-drug interaction. Front Biosci (Elite Ed) 2010, 2, 241-249. 92. Wang, L.; Li, W.; Garcia, M.; Lilly, M.; Mercola, D.; Martins-Green, M., Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis. Molecular Biology of the Cell 2013, 24, 2321-30. 93. Hung, T. W.; Chen, P. N.; Wu, H. C.; Wu, S. W.; Tsai, P. Y.; Hsieh, Y. S.; Chang, H. R., Kaempferol inhibits the invasion and migration of renal cancer cells through the downregulation of AKT and FAK pathways. International Journal of Medical Sciences 2017, 14 (10), 984-993. 94. Chang, J. H.; Lai, S. L.; Chen, W. S.; Hung, W. Y.; Chow, J. M.; Hsiao, M.; Lee, W. J.; Chien, M. H., Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways. Biochimica Et Biophysica Acta-Molecular Cell Research 2017, 1864 (10), 1746-1758. 95. Araki, K.; Shimura, T.; Suzuki, H.; Tsutsumi, S.; Wada, W.; Yajima, T.; Kobayahi, T.; Kubo, N.; Kuwano, H., E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. British Journal of Cancer 2011, 105 (12), 1885-1893. 96. Calabrese, E. J., Hormesis: a revolution in toxicology, risk assessment and medicine. EMBO Rep 2004, 5 Spec No (Suppl 1), S37-S40. 97. Lehne, G., P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets 2000, 1 (1), 85-99. 98. Cheung, Kevin J.; Gabrielson, E.; Werb, Z.; Ewald, Andrew J., Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 2013, 155 (7), 1639-1651. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73927 | - |
dc.description.abstract | 根據衛福部國民健康署的統計,台灣大腸直腸癌的發生率連續十三年位居癌症第一名。大腸直腸癌的發展由良性瘜肉開始,再經過基因突變、危險因子等使之轉變為癌化的腺瘤,最後演變成具有侵略性的腺癌並進行遠端轉移。初期大腸直腸癌五年存活率高達90%,而若發展為遠端轉移,則五年存活率只剩14%。中國橄欖(Canarium album L.)富含多種植化素如gallic acid, ellagic acid, methyl gallate, ethyl gallate等,其果實與其他部位分離出來的純物質已被證實具有許多生理機能效果,例如調節脂質代謝、改善代謝異常、抗氧化等功效,而中國橄欖萃取物對癌細胞的影響也分別在動物與細胞實驗中證實。本實驗室先前研究指出中國橄欖水萃物殘渣甲醇萃取乙酸乙酯區分層(CO-EtOAc, COE) 在異位大腸癌小鼠模式中具有抑制大腸癌細胞增生之功效。細胞模式也確認COE對HCT116人類大腸癌細胞有抑制增生、誘導細胞凋亡的效果,並透過蛋白質體學探討分子機制發現COE會活化p53蛋白以促進細胞週期停滯,進而誘導細胞凋亡。本研究使用LC-MS/MS分析COE內純物質成分以探討COE抑制腸癌細胞增生的功效性成分,發現主要的功效性成分為gallic acid,同時發現其需要COE內其他微量物質以達到近似高劑量COE (400 μg/mL)的效果,另外亦驗證gallic acid加上低劑量COE (25 μg/mL)可藉由誘導p53蛋白以促進細胞凋亡。在轉移部份研究發現COE具有抑制癌細胞遷移(migration)及侵入(invasion)的效果,且具有劑量效應,進一步探討分子機制顯示COE可以抑制Src及FAK蛋白表現量及β-catenin易位進核的現象,且會促進細胞貼盤的能力,可能為COE抑制細胞遷移及侵入的原因。 | zh_TW |
dc.description.abstract | According to the National Health Administration of the Ministry of Health and Welfare, the incidence of colorectal cancer in Taiwan has ranked first among cancers for 13 years. The development of colorectal cancer begins with benign polyps, and then turns into cancerous adenomas through genetic mutations and risk factors, and finally develops into aggressive adenocarcinomas with distant metastasis. The five-year survival rate for early colorectal cancer is as high as 90%. However, if it develops to distant metastasis, the five-year survival rate is only 14%. Chinese olive (Canarium album L.) is rich in many plant chemicals such as gallic acid, ellagic acid, methyl gallate, ethyl gallate, etc. The pure compounds separated from the fruit and other parts of Chinese olive have many physiological functions, such as regulating lipids metabolism, improving of abnormal metabolism, anti-oxidation, and other functions. The effects of Chinese olive extract on cancer have also been confirmed in animal and cell models. Our laboratory's previous research indicated that the ethyl acetate soluble fraction of methanol extraction from Chinese olive water-insoluble residue showed the inhibitory effect on the proliferation of colorectal cancer cells in a syngeneic mouse model. The cell model results also confirmed that COE inhibited cell proliferation and induced apoptosis in human HCT116 colorectal cancer cells. Through proteomics to explore the molecular mechanism, we claimed that COE can activate p53 protein to promote cell cycle arrest and induce cell apoptosis. In this study, LC-MS/MS was used to analyze the components in COE to explore the functional ingredients of COE for inhibiting the proliferation of human colorectal cancer cells. The main functional ingredient was gallic acid, but it required other tiny compounds in COE to achieve an approximate effect of the high-dose COE (400 μg/mL), and we also verified that gallic acid pulsed low-dose COE (25 μg/mL) could induce p53 protein to promote cell apoptosis. In addition, COE could inhibit the migration and invasion of cancer cells with dose-dependent effect. Further investigation of the molecular mechanism shows that COE could inhibit the expression of Src and FAK protein and translocation of β-catenin into the nucleus, and promote the ability of cells adhesion, which may cause the inhibition of cell migration and invasion of COE. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T08:13:59Z (GMT). No. of bitstreams: 1 U0001-2701202117290800.pdf: 4608415 bytes, checksum: f8678447be1de18788ca0bf78715f70d (MD5) Previous issue date: 2021 | en |
dc.description.tableofcontents | 謝誌 I 摘要 II Abstract III 目錄 V 圖目錄 VIII 表目錄 IX 縮寫表 X 第一章 文獻回顧 1 第一節 大腸直腸癌(Colorectal cancer, CRC) 1 1. 大腸直腸癌分級 1 2. 大腸直腸癌致病機制 2 3. 大腸直腸癌轉移 2 第二節 癌症細胞凋亡及轉移相關機制 3 1. 細胞凋亡(apoptosis) 3 2. 癌症轉移(metastasis) 3 第三節 中國橄欖(Canarium album L.) 8 1. 中國橄欖的成分分析 8 2. 中國橄欖的生理活性 8 3. 中國橄欖萃取物COE抗大腸直腸癌功效性成分 9 第二章 研究目標與實驗架構 12 第一節 研究目標 12 第二節 實驗架構 13 第三章 材料與方法 14 第一節 實驗材料 14 1. 中國橄欖水萃物殘渣甲醇萃取乙酸乙酯層(CO-EtOAc, COE) 14 2. 化學藥品 15 3. 抗體 17 4. 商業套組 18 5. 儀器設備 18 6. 數據處理軟體 19 第二節 實驗方法 20 1. LC-MS/MS化學分析 20 2. 細胞培養 22 3. 細胞存活率實驗 23 4. 細胞凋亡檢測 24 5. 細胞總蛋白質與細胞核/質蛋白萃取 24 6. BCA蛋白定量法 26 7. 西方墨點法(western blot) 26 8. 免疫細胞螢光染色(immunocytochemistry/immunofluorescence, ICC/IF) 28 9. 細胞遷移與侵入實驗(cell migration invasion assay) 29 10. 統計分析 30 第四章 實驗結果 31 第一節 使用LC-MS/MS進行COE定性與定量分析 31 第二節 Gallic acid為COE內抑制HCT116細胞存活率的功效性成分 33 1. 細胞存活率之MTT assay實驗條件測試 33 2. COE內主要化合物對細胞存活率的影響 34 3. Gallic acid+低劑量COE可顯著抑制細胞存活率 38 第三節 Gallic acid+低劑量COE可促進HCT116之細胞凋亡及p53活化 42 第四節 COE抑制HCT116 p53-/-細胞遷移及侵入 51 1. COE抑制細胞遷移與侵入 51 2. Transwell assay實驗條件之細胞存活率測試 54 3. 探討COE抑制細胞遷移的功效性成分 58 第五節 COE抑制HCT116 p53-/-細胞遷移及侵入的機制探討 61 1. COE對HCT116 p53-/-細胞中EMT相關蛋白的影響 61 2. COE對HCT116 p53-/-細胞貼盤能力與Src/FAK pathway的影響 64 第五章 討論 68 第一節 COE抑制HCT116細胞存活率之功效性成分探討 68 1. 化學分析的方法學比較 68 2. 化合物添加於gallic acid而造成細胞存活率上升的結果探討 68 第二節 COE抑制HCT116 p53-/-細胞遷移與侵入之機制探討 69 第三節 COE在有無FBS的情況下造成細胞型態改變 69 第六章 結論 71 參考文獻 72 附錄 84 | |
dc.language.iso | zh-TW | |
dc.title | 中國橄欖萃取物及其主要成分對大腸直腸癌細胞的抑制功效 | zh_TW |
dc.title | The inhibitory effect Chinese olive (Canarium album L.) extract and its major components on human colorectal cancer cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 109-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 廖憶純(Yi-Chun Liao),蘇純立(Chun-Li Su),郭靜娟(Ching-Chuan Kuo) | |
dc.subject.keyword | 大腸直腸癌,轉移,中國橄欖萃取物,功效性成分,機制, | zh_TW |
dc.subject.keyword | Colorectal cancer,metastasis,Chinese olive extract,functional ingredients,mechanism, | en |
dc.relation.page | 88 | |
dc.identifier.doi | 10.6342/NTU202100211 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2021-01-28 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-2701202117290800.pdf 目前未授權公開取用 | 4.5 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。